JPH1160485A - Pharmaceutical composition for treatment of exoparasitic acetabulum infectious disease of fish and fish feed - Google Patents

Pharmaceutical composition for treatment of exoparasitic acetabulum infectious disease of fish and fish feed

Info

Publication number
JPH1160485A
JPH1160485A JP9230316A JP23031697A JPH1160485A JP H1160485 A JPH1160485 A JP H1160485A JP 9230316 A JP9230316 A JP 9230316A JP 23031697 A JP23031697 A JP 23031697A JP H1160485 A JPH1160485 A JP H1160485A
Authority
JP
Japan
Prior art keywords
fish
feed
pharmaceutical composition
treatment
exoparasitic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP9230316A
Other languages
Japanese (ja)
Inventor
Noritaka Hirasawa
徳高 平澤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissui Corp
Original Assignee
Nippon Suisan Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Suisan Kaisha Ltd filed Critical Nippon Suisan Kaisha Ltd
Priority to JP9230316A priority Critical patent/JPH1160485A/en
Publication of JPH1160485A publication Critical patent/JPH1160485A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a pharmaceutical composition effective against exoparasitic acetabula, a pharmaceutical composition for treatment of heterobothrium infectious diseases in Fugu rubripes, and pharmaceutical feed. SOLUTION: This pharmaceutical composition is a composition for treatment of exoparasitic acetabula infectious diseases of fish, including praziquantel as an active ingredient. This composition is used for oral treatment, being a composition for feed. The fish is Fugu rubripes rubripes, and the exoparasitic acetabula infectious disease is heterobothium infectious disease.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業の属する技術分野】本発明は、トラフグのヘテロ
ボツリウム感染症などの魚類の外部寄生多後吸盤類感染
症の治療のための薬剤組成物および魚類飼料に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a pharmaceutical composition and a fish feed for the treatment of ectoparasitic multiple posterior sucker infections of fish such as Heteroboturium infections of Trafugu.

【0002】[0002]

【従来の技術】魚類養殖に際して魚類外部寄生虫の被害
が著しく、その適確な駆除が要望されている。例えば、
トラフグ養殖において、寄生虫症は安定生産の妨げとな
るため、非常に大きな問題となっている。寄生虫症の中
でも、ヘテロボツリウム感染症は日本のどの漁場でも発
生するため、トラフグにとって最も問題とされている。
トラフグの寄生虫であるヘテロボツリウム〔単生類ディ
クリドフォラ科のHeterobothrium okamotoi(トラフグ
えらむし)〕は、トラフグのみに寄生して、エラとその
周辺より吸血を行うため、トラフグは貧血状態になり成
長不良を起こす。本虫の生活史は、卵から孵化後4〜5
カ月で一生を終えると考えられている。卵から孵化した
仔虫がまず鰓に寄生し、そこで幼虫となり、5〜6mm
程度に成長すると鰓を囲む組織に移動して、把握器側を
組織内に埋め親虫となり産卵する。
2. Description of the Related Art Fish ectoparasites are significantly damaged during fish cultivation, and there is a demand for their proper control. For example,
Parasitic disease has become a very serious problem in trout cultivation because it hinders stable production. Among the parasitic diseases, heterobotulium infections are the most problematic for Trafugu, as they occur in any fishing ground in Japan.
Heterobothrium (Heterobothrium okamotoi ( Monophoridae )), a parasite of Torafugu , parasitizes only to Torafugu and sucks blood from Ellah and its surroundings. Cause The life history of this insect is 4 to 5 after hatching from the egg.
It is thought to end his life in months. Larvae hatched from eggs first parasitize the gills, where they become larvae, 5-6 mm
When it grows to the extent, it moves to the tissue surrounding the gill and embeds the grasper side in the tissue to become a parent insect and lay eggs.

【0003】鰓弁上の幼虫、鰓腔壁の成虫ともに、薬剤
や浸透圧の変化にきわめて抵抗性が強く、現在までのと
ころ、有効な駆虫法は開発されていない。現場での本虫
に対する対策は、魚を定期的に800ppm前後のホル
マリンで1時間程度薬浴することぐらいしかない。しか
し、この処理では幼虫を80%程度しか駆除できず、さ
らに親虫に至っては、体の一部を宿主組織内に埋没させ
ているので、衰弱しても脱落することはない。また、ホ
ルマリンは発ガン性の物質であり、環境汚染等の点から
問題が生じている。このことから、魚類養殖に際して魚
類外部寄生虫の適確な駆除の目的のため経口で低濃度で
寄生虫に対して有効な薬剤、天然物質の開発は必須であ
る。
Both the larva on the gill flap and the adult on the gill cavity wall are extremely resistant to changes in drugs and osmotic pressure, and no effective anthelmintic method has been developed so far. The only countermeasure against this insect at the site is to regularly bathe the fish with about 800 ppm of formalin for about one hour. However, with this treatment, only about 80% of the larvae can be controlled, and even the parent larvae do not fall off even if weakened, because a part of the body is buried in the host tissue. In addition, formalin is a carcinogenic substance, and poses a problem in terms of environmental pollution and the like. For this reason, it is indispensable to develop drugs and natural substances that are effective against parasites at low concentrations orally for the purpose of properly controlling fish ectoparasites during fish farming.

【0004】[0004]

【発明が解決しようとする課題】本発明は、外部寄生多
後吸盤類に対して効果を有する魚類用薬剤組成物の提供
を目的としている。本発明は、トラフグのヘテロボツリ
ウム感染症の治療のための薬剤組成物および医薬飼料を
提供することを目的としている。
SUMMARY OF THE INVENTION An object of the present invention is to provide a pharmaceutical composition for fish which is effective against ectoparasitic polyps. An object of the present invention is to provide a pharmaceutical composition and a feed for treating heterobotulium infection of Trafugu.

【0005】[0005]

【課題を解決するための手段】本発明は、プラジカンテ
ルを有効成分とすることを特徴とする魚類の外部寄生多
後吸盤類感染症の治療のための薬剤組成物を要旨として
いる。上記組成物は好ましくは経口処置用のものであ
る。また、本発明は、上記薬剤組成物を含有することを
特徴とする魚類飼料を要旨としている。本発明は、プラ
ジカンテルを有効成分とすることを特徴とするトラフグ
のヘテロボツリウム感染症の治療のための薬剤組成物を
要旨としている。上記組成物は好ましくは経口処置用の
ものである。また、本発明は、上記薬剤組成物を含有す
ることを特徴とするトラフグ用飼料を要旨としている。
The gist of the present invention is to provide a pharmaceutical composition for treating ectoparasitic multiple posterior sucker infections in fish, which comprises praziquantel as an active ingredient. The composition is preferably for oral treatment. The present invention also provides a fish feed characterized by containing the above-mentioned drug composition. The gist of the present invention is a pharmaceutical composition for treating Heterobotulium infection of Trafugu, comprising praziquantel as an active ingredient. The composition is preferably for oral treatment. In addition, the present invention provides a feed for a tiger puffer characterized by containing the above-mentioned drug composition.

【0006】[0006]

【発明の実施の形態】多後吸盤類は、扁形動物門単生綱
に属する。単生虫は、扁形動物門の単生綱に属する。雌
雄同体で、ほとんどが魚の外部寄生虫である。体長は1
mm以下の小型種から数cmに達するものまである。主
として後端にある魚への固着器官の構造によって単後吸
盤類と多後吸盤類に分けられる。多後吸盤類に属する主
な寄生虫の分類群と種名、《寄生虫の特徴》、[主な感
染魚・病名]は、ミクロコチレ セバスチス(Microcot
yle sebastisci)、《把握器2列、総数30〜60》、
[カサゴのミクロコチレ]、ビバギナ タイ(Bivagina
tai)、《把握器2列、総数80以上》、[マダイのビ
バギナ症],ヘテラキシン ヘテロセルカ(Heteraxine
heterocerca)、《左右不相称、把握器列は長さ異な
る》、[ブリのえらむし症]、ヘテロボツリウム オカ
モトイ(Heterobothrium okamotoi)、《把握器2列、
各4個》、[トラフグのヘテロボツリウム症]オイディ
プルズーン ニッポニカム(Eudiplozoon nipponicum) 、
《把握器2列、2虫がX字状に合体》、[コイ、フナの
フタゴムシ症]である。
BEST MODE FOR CARRYING OUT THE INVENTION The multiple suckers belong to the phylum Monophyta. Monoplasias belong to the monophyta of the phyla. Hermaphroditic, mostly ectoparasites of fish. Length is 1
They range from small species of less than mm to several cm. It is mainly divided into single-post suckers and multi-post suckers according to the structure of the organs attached to the fish at the rear end. The taxonomic groups and species names of the main parasites belonging to the polypodal suckers, “Characteristics of the parasite”, and the name of the main infected fish / disease are the names of Microcot .
yle sebastisci ), << 2 rows of graspers , total 30-60 >>,
[Scorpion Micro Kochire], Bivagina Thailand ( Bivagina
tai ), << 2 rows of graspers, total number of more than 80 >>, [Vivaginosis of red sea bream], Heteraxine Heteraxine
heterocerca ), << Left and right asymmetry, length of grasping device row is different >>, [Bellied sting disease], Heterobothrium okamotoi ( Heterobothrium okamotoi ), << Two rows of grasping device,
4 each), [Heterobotulism in Trafugu] Eudiplozoon nipponicum ,
"Two rows of graspers, two insects united in an X-shape", and [Carp and crucian carp scabies].

【0007】本発明で使用する“プラジカンテル”は、
化学名で(±)-2-(シクロヘキシルカルボニル)-1,
2,3,6,7,11-ヘキサヒドロ-4-ピラジノ-〔2,1-
α〕イソキノリン-4-オンと呼ばれるピラジノイソキノ
リン系の化合物であり、人間の肝吸虫症、肺吸虫症に対
する駆除薬である。
[0007] “Pradicantel” used in the present invention is
The chemical name is (±) -2- (cyclohexylcarbonyl) -1,
2,3,6,7,11-hexahydro-4-pyrazino- [2,1-
α] Isoquinolin-4-one is a pyrazinoisoquinoline-based compound called a pesticidal agent against human flukemic and paragonimiasis.

【0008】本剤は速やかに吸虫体に取り込まれ、外皮
膜リン脂質との相互作用により吸虫の膜構造を不安定化
し、吸虫へのCa++の流入を促進する。吸虫体内に流入
したCa++は吸虫の筋収縮及び吸虫外皮の構造的損傷
(空胞化等)を起し虫体を致死させる。ヘテロボツリウ
ムの幼虫、親虫を本剤を含む溶液に浸せきすると、人間
の吸虫同様に空胞化を呈し、致死することが観察され
た。
The present agent is rapidly taken up by the fluke body, destabilizes the membrane structure of the fluke due to the interaction with the outer membrane phospholipid, and promotes the influx of Ca ++ into the fluke. Ca ++ that has flowed into the fluke body causes muscle contraction of the fluke and structural damage (vacuumization etc.) of the fluke outer skin and kills the fluke body. It was observed that when larvae and parent worms of heterobotulium were immersed in a solution containing this agent, they became vacuolated and killed, as did human fluke.

【0009】そこで、トラフグの寄生虫症であるヘテロ
ボツリウム感染に対するプラジカンテルの効果について
検討した。すなわち、プラジカンテルをトラフグの餌に
添加し、投与することでヘテロボツリウム症の感染防
止、ならびに本症を治癒させることが可能か否かを検討
し、後述の実施例に示すように本剤のヘテロボツリウム
感染に対する治癒効果が認められた。
Therefore, the effect of praziquantel on heterobotulium infection, a parasitosis of Trafugu, was examined. That is, by adding praziquantel to the food of Trafugu and administering it, it was examined whether it is possible to prevent the infection of heterobotulitis and cure the disease, and as shown in the Examples below, A curative effect on heterobotulium infection was observed.

【0010】本発明において、プラジカンテルをペレッ
ト、顆粒、錠剤など任意の形態の医薬飼料として使用す
る場合、飼料中に0.0001〜5重量%の濃度で含む
のが好ましい。プラジカンテルの導入は、飼料製造の技
術的に適当な段階で、最終製品において均一に分配され
るように行われる。
In the present invention, when praziquantel is used as an optional form of a pharmaceutical feed such as pellets, granules and tablets, it is preferably contained in the feed at a concentration of 0.0001 to 5% by weight. The introduction of praziquantel is carried out at the technically relevant stage of the production of the feed such that it is evenly distributed in the final product.

【0011】本発明の飼料の組成あるいは製法は特に限
定されるものではなく、プラジカンテルを添加したもの
であればいずれの養魚用飼料でもよい。例えば、タンパ
ク質、でんぷん質、水分および油分を必須成分として含
有し、でんぷん質は少なくとも小麦粉およびでんぷんか
らなり、小麦粉中のグルテンを網状化させて5〜30重
量%の範囲の油分および15〜40重量%の範囲水分を
網状化組織中に封じ込めた、柔軟で弾力性のある多孔性
養魚飼料が用いられる。こうした多孔性高脂質養魚飼料
は、通常の養魚飼料の原材料とほぼ同じものを用いるこ
とができ、魚粉、大豆油かす、コーングルテンミールな
どのタンパク質、でんぷん粉、小麦粉などのでんぷん質
にビタミン、ミネラル類を含有するが、特に5〜30重
量%の範囲の油分および15〜40重量%の範囲の水分
含有することを特徴とする。でんぷん質原料としては、
小麦粉およびでんぷんを必須成分とする。でんぷんは目
的とする養魚用飼料の硬度などに応じ、とうもろこし、
小麦、米、タピオカ、マイロ、ソルガム、馬れいしょ、
甘藷、サゴヤシなど種々の種類のでんぷんが使用でき
る。柔らかさと弾力性をあわせもつ成形飼料とするため
に、タピオカでんぷんが好ましい。養魚飼料原料に油脂
を添加後、水を加えて加圧加熱用押出機で加熱混練して
製造する。このような量で油分を高含量で含有させると
魚の成長促進においてすぐれた効果が得られる。油分
は、魚粉などの原材料由来の脂肪分に加えて、動物性油
脂や植物性油脂が含まれる。油脂としては高度不飽和脂
肪酸のω3系脂肪酸を含むものが好ましく、融点が−2
0〜50℃のものを用いるのが好ましい。ここで加水量
としては押し出し成形後乾燥して水分を15〜40%の
範囲のものを得るのに適した状態になるように15〜4
5%の水を加えるのがよい。多孔性の柔らかい物性を持
っているため、摂餌性も良好でさらに魚類消化管内にお
ける消化性も優れている。飼料中の水分が高いために生
理障害も発生しにくい。そして、飼料中の油分も魚類の
成長段階に合わせた最適要求量に調節することができ
る。
The composition or production method of the feed of the present invention is not particularly limited, and any feed for fish farming may be used as long as praziquantel is added. For example, it contains protein, starch, moisture and oil as essential components, and the starch consists of at least flour and starch, and the gluten in the flour is reticulated to provide an oil content in the range of 5 to 30% by weight and 15 to 40% by weight. A flexible, resilient, porous fish feed with% moisture in the reticulated tissue is used. These porous high-lipid fish feeds can use almost the same raw materials as ordinary fish feeds. , But is characterized by an oil content in the range of 5 to 30% by weight and a water content in the range of 15 to 40% by weight. As a starch raw material,
Flour and starch are essential ingredients. Starch depends on the hardness of the target fish feed, etc.
Wheat, rice, tapioca, milo, sorghum, horseradish,
Various types of starch such as sweet potatoes and sago palm can be used. Tapioca starch is preferred in order to obtain a molded feed having both softness and elasticity. After adding fats and oils to the raw material for fish farming, water is added, and the mixture is heated and kneaded by a pressurizing and heating extruder to produce. When the oil content is high in such an amount, an excellent effect in promoting the growth of fish can be obtained. The oil content includes animal fats and vegetable fats and oils in addition to fats derived from raw materials such as fish meal. As the fats and oils, those containing ω3 fatty acids of highly unsaturated fatty acids are preferable, and the melting point is −2.
It is preferable to use one having a temperature of 0 to 50 ° C. Here, the amount of water added is adjusted so as to be in a state suitable for obtaining a water content of 15 to 40% by drying after extrusion molding.
It is better to add 5% water. Due to its porous and soft physical properties, it has good feeding and good digestibility in fish digestive tract. Physiological disorders are less likely to occur due to the high water content of the feed. The oil content of the feed can also be adjusted to the optimum required amount according to the growth stage of the fish.

【0012】[0012]

【実施例】本願発明の詳細を実施例で説明する。本願発
明はこれら実施例によって何ら限定されるものではな
い。
DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described in detail with reference to embodiments. The present invention is not limited by these examples.

【0013】実施例1 [方法]プラジカンテル バイエル製薬(株)で販売されているプラジカンテル錠
を粉砕し、試験に用いた。供試魚 平均魚体重約63.6gのトラフグを試験に用いた。試験区 プラジカンテル添加飼料を給餌するプラジカンテル添加
区と無添加飼料を給餌する対照区の計2区とした。ま
た、各区魚体重に対し、1%給餌とした。この時のプラ
ジカンテル投与量は40mg/魚体重/日であった。試験飼料 試験飼料の組成を表1〔試験飼料組成(%)〕に示す。
Example 1 [Method] Praziquantel tablets sold by Praziquantel Bayer Pharmaceutical Co., Ltd. were pulverized and used for the test. Test fish An average fish weight of about 63.6 g was used for the test. There were a total of two sections: a praziquantel-added group fed with a test group praziquantel-added feed and a control section fed with non-added feed. In addition, 1% of the body weight of each section was fed. The dose of praziquantel at this time was 40 mg / fish body weight / day. Test feed composition of the test feed is shown in Table 1 [Test feed composition (%)].

【0014】[0014]

【表1】 ───────────────────────────────── 試験区 ─────────────────── 原料 プラジカンテル添加 対照 ───────────────────────────────── ミネラル 0.2 0.2 リン酸カルシウム 0.8 0.8 ビタミンミックス 2.0 2.0 CMC 2.0 2.0 活性グルテン 5.0 5.0 ブラウンミール 34.0 34.0 ホワイトミール 25.0 25.0 イカミール 5.0 5.0 オキアミミール 10.0 10.0 コメヌカ 9.388 10.0 フィードイオル 6.0 6.0 プラジカンテル 0.612 − ─────────────────────────────────[Table 1] ───────────────────────────────── Test area ───────────原料 Raw material praziquantel added control ───────────────────────────────── Mineral 0.20 .2 Calcium phosphate 0.8 0.8 Vitamin mix 2.0 2.0 CMC 2.0 2.0 Active gluten 5.0 5.0 Brown meal 34.0 34.0 White meal 25.0 25.0 Ika meal 5 5.0 5.0 krill meal 10.0 10.0 10.0 rice bran 9.388 10.0 feed iol 6.0 6.0 praziquantel 0.612-───────────────── ────────────────

【0015】攻撃試験試験 ヘテロボツリウム感染等の疾病の認められない群の魚1
2尾(正常魚)をそれぞれ100リットル水槽に収容
し、各試験飼料を給餌した。7日後に予めヘテロボツリ
ウム約50個体を感染させた魚6尾(感染魚)を各試験
区に追加し、83日間試験飼料で継続飼育した。また、
この時の感染魚の虫のステージは親であった。混養を開
始して30日経過時に、各区から感染魚2尾、正常魚4
尾をサンプリングし、鰓に寄生している本虫の数を測定
した。試験期間中の水温は、混養30日経過時まで1
5.8℃とした。それ以降自然水温とし、試験終了時は
19.0℃であった。試験期間中の換水は20回転/日
とした。評価は、試験期間中の各区の死亡状況を比較す
ること、治癒効果ならびに感染防止効果を調べるため各
区感染魚の鰓の寄生数を測定し比較することで行った。
Attack test test Fish 1 of a group free from diseases such as heterobotulium infection
Two fish (normal fish) were each housed in a 100-liter water tank, and each test feed was fed. Seven days later, six fish (infected fish) which had been infected with about 50 heterobotulium individuals in advance were added to each test group, and were continuously kept on the test feed for 83 days. Also,
The stage of the infected fish at this time was the parent. 30 days after commencement of feeding, 2 infected fish and 4 normal fish from each section
The tail was sampled, and the number of parasites parasitizing the gills was measured. The water temperature during the test period is 1 until 30 days after mixing.
5.8 ° C. Thereafter, the temperature was set to the natural water temperature, and was 19.0 ° C. at the end of the test. Water exchange during the test period was 20 revolutions / day. Evaluation was performed by comparing the mortality status of each section during the test period, and measuring and comparing the number of gill parasites of the infected fish in each section to examine the healing effect and the infection prevention effect.

【0016】[結果と考察]試験終了時の感染魚の生残
は、プラジカンテル添加区が100%、対照区が生残率
50%であり、本剤の効果が認められた(図1)。感染
魚の鰓の本虫の寄生数は、混養30日経過時では両区と
もに差顕著な差が認められなかった(図3)。しかし、
試験終了時に生残していたプラジカンテル添加区の感染
魚に親虫、幼虫の寄生はほぼ認められず、明らかに本剤
のヘテロボツリウム感染に対する治癒効果が認められた
(図4)。これらの結果から、プラジカンテルは孵化仔
虫の感染に対する感染阻止効果ではなく、親虫に対し、
寿命を短くするような効果を持っていること、幼虫が親
虫になるのを阻止する効果を持っていること等が考えら
れた。
[Results and Discussion] At the end of the test, the survival rate of the infected fish was 100% in the praziquantel-added group and 50% in the control group, indicating the effect of the present drug (FIG. 1). No significant difference was observed between the two groups in the number of parasites of this insect on the gills of the infected fish after 30 days of feeding (FIG. 3). But,
Parasite and larva parasitism was almost not observed in the infected fish in the praziquantel-added group that survived at the end of the test, and a clear healing effect of this drug against heterobotulium infection was observed (FIG. 4). From these results, praziquantel is not an inhibitory effect on hatchling larvae infection,
It was thought that it had the effect of shortening the lifespan and that it had the effect of preventing larvae from becoming parents.

【0017】一方正常魚の生残は、添加区が100%、
対照区が25%であり、プラジカンテルの効果が前述同
様に認められた(図2)。正常魚の鰓の本虫の寄生数
は、感染魚と同様な傾向を示した(図5、図6)。以上
の結果から、プラジカンテルを餌に添加し、魚に経口投
与することにより、ヘテロボツリウム感染魚に対し治癒
効果が確認された。
On the other hand, the survival of normal fish was 100%
The control group was 25%, and the effect of praziquantel was recognized as described above (FIG. 2). The number of parasites of the gills of the gills of the normal fish showed the same tendency as that of the infected fish (FIGS. 5 and 6). From the above results, it was confirmed that by adding praziquantel to the diet and orally administering it to the fish, a healing effect was obtained for the fish infected with heterobotulium.

【0018】[0018]

【発明の効果】餌にまぜて投与することにより、飼育環
境全体が処理される不利益がなく、外部寄生多後吸盤類
に対して効果を有し、例えばトラフグのヘテロボツリウ
ム感染症の治療をすることができる。
EFFECTS OF THE INVENTION By mixing with food, there is no disadvantage that the whole breeding environment is treated, and it has an effect on ectoparasitic multiple suckers, for example, treatment of Heterobothrium infection of Trafugu Can be.

【図面の簡単な説明】[Brief description of the drawings]

【図1】試験区間における感染魚の生残比較(n=4)
を示す図面である。
FIG. 1 Comparison of survival of infected fish in the test section (n = 4)
FIG.

【図2】試験区間における正常魚の生残比較(n=8)
を示す図面である。
FIG. 2 Comparison of survival of normal fish in the test section (n = 8)
FIG.

【図3】30日経過時における感染魚の虫体寄生数の比
較(n=2)を示す図面である。
FIG. 3 is a drawing showing a comparison (n = 2) of the number of parasites in infected fish after 30 days.

【図4】試験終了時(83日経過)に生残していた感染
魚の虫体寄生数の比較(プラジカンテル添加区;n=
4、対照区;n=2)を示す図面である。
FIG. 4 shows a comparison of the number of parasites of infected fish that survived at the end of the test (83 days) (Pradicantel-added group; n =
4 is a drawing showing a control group; n = 2).

【図5】30日経過時における正常魚の本虫寄生数の比
較(n=4)を示す図面である。
FIG. 5 is a drawing showing comparison (n = 4) of the number of parasites of normal fish after 30 days.

【図6】試験終了時(83日経過)に生残していた正常
魚の本虫寄生数の比較(プラジカンテル添加区;n=
8、対照区;n=2)を示す図面である。
FIG. 6: Comparison of the number of parasitoids of normal fish that survived at the end of the test (after 83 days) (Pradicantel-added group; n =
8, a control; n = 2).

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 プラジカンテルを有効成分とすることを
特徴とする魚類の外部寄生多後吸盤類感染症の治療のた
めの薬剤組成物。
1. A pharmaceutical composition for treating ectoparasitic multiple sucker infections in fish, comprising praziquantel as an active ingredient.
【請求項2】 該組成物が経口処置用のものである請求
項1の魚類の外部寄生多後吸盤類感染症の治療のための
薬剤組成物。
2. The pharmaceutical composition according to claim 1, wherein said composition is for oral treatment.
【請求項3】 魚類がトラフグであり、外部寄生多後吸
盤類感染症がヘテロボツリウム感染症である請求項1ま
たは2の魚類の外部寄生多後吸盤類感染症の治療のため
の薬剤組成物。
3. The pharmaceutical composition for the treatment of ectoparasitic polybasic sucker infections in fish according to claim 1 or 2, wherein the fish is Trafugu and the ectoparasitic poly sucker infection is heterobotulium infection. Stuff.
【請求項4】 請求項1、2または3の薬剤組成物を含
有することを特徴とする魚類飼料。
4. A fish feed comprising the pharmaceutical composition according to claim 1, 2 or 3.
JP9230316A 1997-08-11 1997-08-11 Pharmaceutical composition for treatment of exoparasitic acetabulum infectious disease of fish and fish feed Withdrawn JPH1160485A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9230316A JPH1160485A (en) 1997-08-11 1997-08-11 Pharmaceutical composition for treatment of exoparasitic acetabulum infectious disease of fish and fish feed

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9230316A JPH1160485A (en) 1997-08-11 1997-08-11 Pharmaceutical composition for treatment of exoparasitic acetabulum infectious disease of fish and fish feed

Publications (1)

Publication Number Publication Date
JPH1160485A true JPH1160485A (en) 1999-03-02

Family

ID=16905929

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9230316A Withdrawn JPH1160485A (en) 1997-08-11 1997-08-11 Pharmaceutical composition for treatment of exoparasitic acetabulum infectious disease of fish and fish feed

Country Status (1)

Country Link
JP (1) JPH1160485A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002005649A1 (en) * 2000-07-13 2002-01-24 Meiji Seika Kaisha, Ltd. Parasiticide and parasitic method for globefish
KR100358084B1 (en) * 2000-10-04 2002-10-25 주식회사대성미생물연구소 Treatment of gill monogenean disease in fish using praziquantel and cimetidine
JP2004331498A (en) * 2001-01-31 2004-11-25 Meiji Seika Kaisha Ltd Eliminator and method for eliminating parasite from fish

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002005649A1 (en) * 2000-07-13 2002-01-24 Meiji Seika Kaisha, Ltd. Parasiticide and parasitic method for globefish
JP3490709B2 (en) * 2000-07-13 2004-01-26 明治製菓株式会社 Pest control agents and methods for pufferfish parasites
KR100358084B1 (en) * 2000-10-04 2002-10-25 주식회사대성미생물연구소 Treatment of gill monogenean disease in fish using praziquantel and cimetidine
JP2004331498A (en) * 2001-01-31 2004-11-25 Meiji Seika Kaisha Ltd Eliminator and method for eliminating parasite from fish
JP4695766B2 (en) * 2001-01-31 2011-06-08 明治製菓株式会社 Fish parasite control agent and control method

Similar Documents

Publication Publication Date Title
KR101217429B1 (en) Palatable ductile chewable veterinary composition
Adamo et al. Effects of a tachinid parasitoid, Ormia ochracea, on the behaviour and reproduction of its male and female field cricket hosts (Gryllus spp)
JP5881175B2 (en) Use of natural substances as feed additives for aquatic animals
JPS6212A (en) Bait product containing methylsulfonylmethane and use
BR112020026106A2 (en) COMPOSITION, VETERINARY FORMULATION, USE OF A COMPOSITION, FEEDING REGIME, AND METHOD FOR BREEDING ANIMAL.
AU2021104909A4 (en) Use of alpha lipoic acid as a feed additive for aquatic animals
WO2017064092A1 (en) Feed additives for aquatic animals comprising essential oils and lysozyme
Wallace Sphenisciformes (penguins)
JP5771203B2 (en) Fish parasite control agent and control method
Gill Avian skin diseases
KR19980082030A (en) Chinese herbal medicine including sulfur, manufacturing method of feed containing mineral
JP4530307B2 (en) Fish parasite therapeutic agent, method of use and use
AU770392B2 (en) Companion animal therapeutic treat
JPH1160485A (en) Pharmaceutical composition for treatment of exoparasitic acetabulum infectious disease of fish and fish feed
Kubiak Corn Snakes
JP2010077056A (en) Infectious disease prophylactic
Bulbul et al. Avian trichomonosis with special reference to pigeon
CN106721524A (en) A kind of feed of grass carp
JPH0840935A (en) Method of giving immunity against poultry coccidiosis
Goodman Natural history and medical management of waterfowl
JPH11113501A (en) Natural physiologically active substance-containing fish feeding stuff
JP2001122717A (en) Antiparasitic and antimicrobial agent for fishes
Gardner Natural history and medical management of opossums
ES2913405T3 (en) Veterinary compositions for delayed-release feed with ovicidal and larvicidal activity against susceptible and resistant strains of parasites in ruminant feces, use of these compositions, method for delaying the release of these compositions
JP3212364B2 (en) New royal jelly formulation

Legal Events

Date Code Title Description
A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20041102